WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004004715) NOVEL DELTA OPIOID RECEPTOR LIGANDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/004715    International Application No.:    PCT/EP2003/007400
Publication Date: 15.01.2004 International Filing Date: 08.07.2003
Chapter 2 Demand Filed:    30.01.2004    
IPC:
A61K 31/44 (2006.01), C07D 213/74 (2006.01), C07D 401/04 (2006.01), C07D 401/12 (2006.01), C07D 401/14 (2006.01), C07D 405/14 (2006.01)
Applicants: GLAXOSMITHKLINE SPA [IT/IT]; Via Alessandro Fleming 2, I-37135 Verona (IT) (For All Designated States Except US).
DONDIO, Giulio [IT/IT]; (IT) (For US Only).
MACECCHINI, Silvia [IT/IT]; (IT) (For US Only).
RAVEGLIA, Luca, Francesco [IT/IT]; (IT) (For US Only)
Inventors: DONDIO, Giulio; (IT).
MACECCHINI, Silvia; (IT).
RAVEGLIA, Luca, Francesco; (IT)
Agent: RUTTER, Keith; GlaxoSmithKline, CIP (CN925.1), 980 Great West Road, Brentford, Middlesex TW8 9GS (GB)
Priority Data:
0215867.3 09.07.2002 GB
Title (EN) NOVEL DELTA OPIOID RECEPTOR LIGANDS
(FR) NOUVEAU PROCEDE ET COMPOSES ASSOCIES
Abstract: front page image
(EN)A method for the modulation of conditions associated with the delta opioid receptor, which method comprises the administration to the mammal in need thereof an effective or prophylactic amount of a compound of formula (I): wherein X, Y, Z, R1, and R2 are as defined in the specification; to compounds for use in such a method, to processes for their preparation, and to their use in medicine.
(FR)L'invention concerne un procédé de modulation d'états associés au récepteur opioïde delta. Ce procédé consiste à administrer à un mammifère nécessitant un tel traitement une dose efficace ou prophylactique d'un composé de formule générale (I) dans laquelle X, Y, Z, R1, et R2 ont la signification indiquée dans la description. L'invention concerne également des composés destinés à être utilisés dans ledit procédé, des procédés de préparation associés, et leur utilisation dans le domaine médical.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)